Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
NCT ID: NCT05002335
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2020-10-06
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Radiological Outcomes of Medacta Shoulder System
NCT03547947
Clinical and Radiological Outcomes of Medacta Shoulder System FR
NCT05926622
Mirror Medacta Shoulder System Pivotal Trial
NCT05062252
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System
NCT05358574
Focus on the Humeral Component Following Reverse Shoulder Arthroplasty
NCT04809077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medacta Shoulder System
Performance of Total Shoulder Arthroplasty (anatomic/reverse) with Medacta Shoulder System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with one of the following diagnosis:
1. Primary osteoarthritis
2. Secondary osteoarthritis
3. Cuff tear arthropathy; insufficient rotator cuff
4. Acute fracture (\<21d)
5. Rheumatoid or inflammatory arthritis
6. Avascular necrosis
7. Other posttraumatic condition
8. Revision of shoulder arthroplasty
Exclusion Criteria
* Patients with proven or suspect infections (at the time of surgery)
* Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
* Patients with known incompatibility or allergy to products materials (at the time of surgery)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medacta International SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bart Berghs, MD
Role: PRINCIPAL_INVESTIGATOR
AZ Sint-Jan (Brugge, Belgium)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Sint-Jan
Bruges, , Belgium
AZ Sint-Lucas
Bruges, , Belgium
Clinique St-Luc Bouge
Namur, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P06.001.05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.